Devyser Diagnostics AB (OSTO:DVYSR) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:DVYSR Devyser Diagnostics AB OSTO:DVYSR
67 GF Score
Price kr56.80
GF Value kr130.46
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Devyser Diagnostics AB FFO?

FFO (Funds from operations) only applies to REITs.

OSTO:DVYSR
67GF Score
Devyser Diagnostics AB OSTO:DVYSR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Devyser Diagnostics AB (OSTO:DVYSR) Overvalued in 2026?

Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued. The current stock price of kr56.80 is trading 56.5% below its estimated GF Value™ of kr130.46. GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.

Key valuation signals for OSTO:DVYSR:

  • FFO:
  • GF Value™: kr130.46 vs. price of kr56.80 (56.5% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the OSTO:DVYSR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Devyser Diagnostics AB Business Description

Other Exchanges OL0:Germany
Address Branningevagen 12, Arsta, SWE, 120 54
Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.
67GF Score

Get the complete analysis for OSTO:DVYSR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr56.80
Price
kr130.46
GF Value